Buscar resultados de ensayos clínicos
Hereditary Leiomyomatosis and Renal Cell Cancer - 3 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Condición:
Fecha: 2010-05-25 Intervenciones:
|
Completed |
Nombre del estudio: Randomized Pilot Study for the Treatment of Cutaneous Leiomyomas With Botulinum Toxin Condición:
|
Recruiting |
Nombre del estudio: Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma Condición:
|